NEWS UPDATE

Liveo Research´s pharmaceutical packaging films are registered at CDE in China

L_LKN_CDE-china-registration_reduziert_455px-breit
Share on facebook
Share on twitter
Share on linkedin
Share on xing
Share on whatsapp
Share on email

Liveo Research is pleased to announce an update on its pharmaceutical packaging material portfolio.
As of now Liveo´s films portfolio from low to ultra high barrier level comply with the Chinese Pharmacopeia and are registered at the CDE.

The Center of Drug Evaluation (CDE) belongs to the National Medical Products Administration (NMPA) which issues DMF for primary packaging materials based on a submission dossier. This DMF number is necessary for every drug manufacturer in order fulfill the approval and registration process for their products in China. During the approval process the NMPA can access the information stored in the DMF.

With this achievement Liveo´s materials can be used for the packaging of solid drug products which are intended to be registered in China. The DMF numbers of packaging materials are essential for selling drug products on the Chinese Market.

Scroll to Top